Your browser doesn't support javascript.
loading
Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
Nimmo, Jacqui T; Verma, Ajay; Dodart, Jean-Cosme; Wang, Chang Yi; Savistchenko, Jimmy; Melki, Ronald; Carare, Roxana O; Nicoll, James A R.
Affiliation
  • Nimmo JT; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Verma A; United Neuroscience, Dublin, Republic of Ireland.
  • Dodart JC; United Neuroscience, Dublin, Republic of Ireland.
  • Wang CY; United Neuroscience, Dublin, Republic of Ireland.
  • Savistchenko J; Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Paris, France.
  • Melki R; Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Paris, France.
  • Carare RO; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Nicoll JAR; Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. J.Nicoll@soton.ac.uk.
Alzheimers Res Ther ; 15(1): 18, 2023 Jan 21.
Article in En | MEDLINE | ID: mdl-36681823
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article Country of publication: United kingdom